{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:50:01Z","timestamp":1782139801234,"version":"3.54.5"},"reference-count":84,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.amjmed.2018.04.029","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T04:44:12Z","timestamp":1525927452000},"page":"1418-1424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Nonanesthetic Effects of Ketamine: A Review Article"],"prefix":"10.1016","volume":"131","author":[{"given":"Jabril","family":"Eldufani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-7524","authenticated-orcid":false,"given":"Alireza","family":"Nekoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0001","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","article-title":"Ketamine in chronic pain management: an evidence-based review","volume":"97","author":"Hocking","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0002","series-title":"Miller's Anaesthesia","article-title":"Intravenous anesthetics","author":"Reves","year":"2014"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0003","series-title":"Anaesthesia at a glance","first-page":"30","author":"Stone","year":"2013"},{"issue":"3","key":"10.1016\/j.amjmed.2018.04.029_bib0004","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pain.2009.06.023","article-title":"Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1","volume":"145","author":"Sigtermans","year":"2009","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.amjmed.2018.04.029_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.annemergmed.2013.08.017","article-title":"Is ketamine effective for the management of acute asthma exacerbations in children?","volume":"63","author":"Maddox","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fped.2014.00024","article-title":"Intravenous ketamine for refractory bronchospasm precipitated by H1N1 infection","volume":"2","author":"Agrawal","year":"2014","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0007","first-page":"430","article-title":"Subanaesthetic dose of ketamine in intractable asthma","volume":"109","author":"Garg","year":"2011","journal-title":"J Indian Med Assoc"},{"issue":"7","key":"10.1016\/j.amjmed.2018.04.029_bib0008","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1034\/j.1399-6576.2003.00187.x","article-title":"The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain","volume":"47","author":"Kvarnstrom","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200724010-00001","article-title":"Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management","volume":"24","author":"Christo","year":"2007","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.amjmed.2018.04.029_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1445-2197.1970.tb05616.x","article-title":"Ketamine: A new anaesthetic agent","volume":"39","author":"Brown","year":"1970","journal-title":"Aust N Z J Surg"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0011","first-page":"31","article-title":"Ketamine associated psychedelic effects and dependence","volume":"44","author":"Lim","year":"2003","journal-title":"Singapore Med J"},{"issue":"8","key":"10.1016\/j.amjmed.2018.04.029_bib0012","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2044.1976.tb11948.x","article-title":"Recurrent hallucinations following ketamine","volume":"31","author":"Perel","year":"1976","journal-title":"Anaesthesia"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0013","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000438675","article-title":"Ketamine-induced hallucinations","volume":"48","author":"Powers","year":"2015","journal-title":"Psychopathology"},{"issue":"4","key":"10.1016\/j.amjmed.2018.04.029_bib0014","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/ALN.0b013e3181b437b1","article-title":"S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers","volume":"111","author":"Sigtermans","year":"2009","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1460-9592.2007.02384.x","article-title":"Investigating the pharmacodynamics of ketamine in children","volume":"18","author":"Herd","year":"2008","journal-title":"Paediatr Anaesth"},{"issue":"5","key":"10.1016\/j.amjmed.2018.04.029_bib0016","first-page":"1186","article-title":"Ketamine: teaching an old drug new tricks","volume":"87","author":"Kohrs","year":"1998","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.amjmed.2018.04.029_bib0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.spen.2016.10.003","article-title":"Pathogenesis of pain","volume":"23","author":"Dinakar","year":"2016","journal-title":"Semin Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0018","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/toxsci\/kfj180","article-title":"Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro","volume":"91","author":"Vutskits","year":"2006","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0019","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.bjp.0706385","article-title":"Ketamine impairs excitability in superficial dorsal horn neurones by blocking sodium and voltage-gated potassium currents","volume":"146","author":"Schnoebel","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/15622975.2016.1224927","article-title":"Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3","volume":"18","author":"Grieco","year":"2017","journal-title":"World J Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.amjmed.2018.04.029_bib0021","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1007\/s12035-015-9562-y","article-title":"Ketamine inhibits ATP-evoked exocytotic release of brain-derived neurotrophic factor from vesicles in cultured rat astrocytes","volume":"53","author":"Stenovec","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/neu.2014.39","article-title":"Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression","volume":"27","author":"Liebenberg","year":"2015","journal-title":"Acta Neuropsychiatr"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0023","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/bja\/77.2.238","article-title":"Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells","volume":"77","author":"Shimaoka","year":"1996","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0024","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1213\/ANE.0000000000001787","article-title":"Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization","volume":"124","author":"Maher","year":"2017","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/bcpt.12637","article-title":"Antinociceptive and anti-inflammatory effects of ketamine and the relationship to its antidepressant action and GSK3 inhibition","volume":"119","author":"do Vale","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5472","key":"10.1016\/j.amjmed.2018.04.029_bib0026","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11916-018-0666-8","article-title":"Chronification of pain: mechanisms, current understanding, and clinical implications","volume":"22","author":"Pak","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0029","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.tcam.2009.12.003","article-title":"Analgesia for anesthetized patients","volume":"25","author":"Lemke","year":"2010","journal-title":"Top Companion Anim Med"},{"issue":"4","key":"10.1016\/j.amjmed.2018.04.029_bib0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.aat.2012.12.001","article-title":"Mechanisms of ketamine-induced immunosuppression","volume":"50","author":"Liu","year":"2012","journal-title":"Acta Anaesthesiol Taiwan"},{"issue":"4","key":"10.1016\/j.amjmed.2018.04.029_bib0031","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1213\/ANE.0000000000001856","article-title":"In vogue: ketamine for neuroprotection in acute neurologic injury","volume":"124","author":"Bell","year":"2017","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0032","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.acn.2007.05.005","article-title":"The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complexregional pain syndrome","volume":"22","author":"Koffler","year":"2007","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0033","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1567202612666150122122924","article-title":"Ketamine treatment partly reverses alterations in brain derived- neurotrophic factor, oxidative stress and energy metabolism parameters induced by an animal model of depression","volume":"12","author":"Reus","year":"2015","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"10.1016\/j.amjmed.2018.04.029_bib0034","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00008877-200305000-00007","article-title":"Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine","volume":"14","author":"De Vry","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0036","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpsychires.2016.12.002","article-title":"Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex","volume":"87","author":"Abelaira","year":"2017","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0037","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2172-12-11","article-title":"Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus","volume":"12","author":"Spentzas","year":"2011","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0038","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0039","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00001756-199306000-00021","article-title":"Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists","volume":"4","author":"Yamakura","year":"1993","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.amjmed.2018.04.029_bib0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.410400512","article-title":"Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease","volume":"40","author":"Masliah","year":"1996","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.amjmed.2018.04.029_bib0041","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","article-title":"Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression","volume":"56","author":"Li","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"10.1016\/j.amjmed.2018.04.029_bib0042","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1213\/00000539-198010000-00008","article-title":"Physostigmine antagonizes ketamine","volume":"59","author":"Toro-Matos","year":"1980","journal-title":"Anesth Analg"},{"issue":"1-2","key":"10.1016\/j.amjmed.2018.04.029_bib0043","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0006-8993(99)01793-X","article-title":"Physostigmine antagonizes ketamine-induced noradrenaline release from the medial prefrontal cortex in rats","volume":"840","author":"Kubota","year":"1999","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0044","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1213\/00000539-199901000-00033","article-title":"The effects of ketamine and propofol on neuronal nicotinic acetylcholine receptors and P2x purinoceptors in PC12 cells","volume":"88","author":"Furuya","year":"1999","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0045","first-page":"57","article-title":"Inhibition by ketamine of muscarinic acetylcholine receptor function","volume":"81","author":"Durieux","year":"1995","journal-title":"Anesth Analg"},{"issue":"11 Suppl 8","key":"10.1016\/j.amjmed.2018.04.029_bib0046","first-page":"S7","article-title":"Anatomy and physiology of glutamate in the CNS","volume":"44","author":"Greenamyre","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0047","first-page":"S116","article-title":"Effects of specific nicotinic acetylcholine receptor agonists on hippocampal long-term potentiation","volume":"7","author":"Rosenbrock","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1-3","key":"10.1016\/j.amjmed.2018.04.029_bib0048","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2011.12.021","article-title":"The effect of sub-anesthetic and anesthetic ketamine on water maze memory acquisition, consolidation and retrieval","volume":"677","author":"Moosavi","year":"2012","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.amjmed.2018.04.029_bib0049","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1570159X12666140619204251","article-title":"The role of ketamine in treatment-resistant depression: a systematic review","volume":"12","author":"Serafini","year":"2014","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2014.12.004","article-title":"Antidepressant actions of ketamine: from molecular mechanisms to clinical practice","volume":"30","author":"Monteggia","year":"2015","journal-title":"Curr Opin Neurobiol"},{"issue":"7354","key":"10.1016\/j.amjmed.2018.04.029_bib0051","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.amjmed.2018.04.029_bib0052","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","article-title":"Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function","volume":"62","author":"Krystal","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0053","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3956(99)00031-X","article-title":"Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans","volume":"34","author":"Vollenweider","year":"2000","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.amjmed.2018.04.029_bib0054","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2012.05.042","article-title":"Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder","volume":"145","author":"Duncan","year":"2013","journal-title":"J Affect Disord"},{"issue":"10","key":"10.1016\/j.amjmed.2018.04.029_bib0056","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0057","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2015.01.022","article-title":"Spine synapse remodeling in the pathophysiology and treatment of depression","volume":"601","author":"Duman","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0058","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnmol.2014.00094","article-title":"Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade","volume":"7","author":"Nosyreva","year":"2014","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0059","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pbb.2016.12.010","article-title":"WY-14643, a selective agonist of peroxisome proliferator-activated receptor-alpha, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in mice","volume":"153","author":"Yang","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.amjmed.2018.04.029_bib0061","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/15622975.2014.922697","article-title":"Pilot dose-response trial of i.v. ketamine in treatment-resistant depression","volume":"15","author":"Lai","year":"2014","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0062","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1213\/ANE.0000000000002594","article-title":"General anesthetics to treat major depressive disorder: clinical relevance and underlying mechanisms","volume":"126","author":"Vutskits","year":"2018","journal-title":"Anesth Analg"},{"issue":"9427","key":"10.1016\/j.amjmed.2018.04.029_bib0063","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/S0140-6736(04)16510-0","article-title":"Strengthening the prevention and care of injuries worldwide","volume":"363","author":"Mock","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0064","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/bja\/aeg028","article-title":"Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury","volume":"90","author":"Hijazi","year":"2003","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1017\/S1481803500012197","article-title":"Myth: ketamine should not be used as an induction agent for intubation in patients with head injury","volume":"12","author":"Filanovsky","year":"2010","journal-title":"CJEM"},{"issue":"3","key":"10.1016\/j.amjmed.2018.04.029_bib0066","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1213\/00000539-199609000-00011","article-title":"The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons","volume":"83","author":"Himmelseher","year":"1996","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0067","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1528-1157.1995.tb00979.x","article-title":"Neuroprotective effect of ketamine administered after status epilepticus onset","volume":"36","author":"Fujikawa","year":"1995","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0068","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.4238\/2015.April.17.4","article-title":"Neuroprotective effect of ketamine on acute spinal cord injury in rats","volume":"14","author":"Tang","year":"2015","journal-title":"Genet Mol Res"},{"issue":"5","key":"10.1016\/j.amjmed.2018.04.029_bib0069","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000542-199205000-00014","article-title":"Ketamine decreases plasma catecholamines and improves outcome from incomplete cerebral ischemia in rats","volume":"76","author":"Hoffman","year":"1992","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.amjmed.2018.04.029_bib0070","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.STR.25.8.1637","article-title":"Therapeutic time window and dose response of the beneficial effects of ketamine in experimental head injury","volume":"25","author":"Shapira","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0071","doi-asserted-by":"crossref","first-page":"e03581","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0072","article-title":"CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage","volume":"2013","author":"Jung","year":"2013","journal-title":"Stroke Res Treat"},{"issue":"1","key":"10.1016\/j.amjmed.2018.04.029_bib0073","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006123-199601000-00004","article-title":"Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage","volume":"38","author":"Saveland","year":"1996","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.amjmed.2018.04.029_bib0074","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/bja\/aem218","article-title":"Low-dose ketamine affects immune responses in humans during the early postoperative period","volume":"99","author":"Beilin","year":"2007","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.amjmed.2018.04.029_bib0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.aat.2012.12.001","article-title":"Mechanisms of ketamine-induced immunosuppression","volume":"50","author":"Liu","year":"2012","journal-title":"Acta Anaesthesiologica Taiwanica"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0076","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.resuscitation.2004.02.015","article-title":"Ketamine improves survival and suppresses IL-6 and TNFalpha production in a model of Gram-negative bacterial sepsis in rats","volume":"62","author":"Shaked","year":"2004","journal-title":"Resuscitation"},{"issue":"6","key":"10.1016\/j.amjmed.2018.04.029_bib0077","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/bja\/aei256","article-title":"Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide","volume":"95","author":"Shibakawa","year":"2005","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.amjmed.2018.04.029_bib0078","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/TA.0000000000000588","article-title":"Ketamine reduces LPS-induced HMGB1 via activation of the Nrf2\/HO-1 pathway and NF-kappaB suppression","volume":"78","author":"Tan","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"10.1016\/j.amjmed.2018.04.029_bib0079","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jss.2015.08.032","article-title":"Ketamine attenuates high mobility group box-1-induced inflammatory responses in endothelial cells","volume":"200","author":"Liu","year":"2016","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.amjmed.2018.04.029_bib0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.200304135","article-title":"Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation","volume":"164","author":"Palumbo","year":"2004","journal-title":"J Cell Biol"},{"issue":"4","key":"10.1016\/j.amjmed.2018.04.029_bib0081","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0082","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-11-106","article-title":"Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro","volume":"11","author":"Sun","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.amjmed.2018.04.029_bib0083","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2010.05728.x","article-title":"Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke","volume":"1207","author":"Hayakawa","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.amjmed.2018.04.029_bib0084","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.05.002","article-title":"HMGB1 level in cerebrospinal fluid as a marker of treatment outcome in patients with acute hydrocephalus following aneurysmal subarachnoid hemorrhage","volume":"24","author":"Sokol","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318304066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318304066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:15:49Z","timestamp":1757582149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934318304066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":84,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0002934318304066"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.04.029","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonanesthetic Effects of Ketamine: A Review Article","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}